CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis. - Wikidata - wikimedia - TriplyDB

CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.

CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.

http://www.wikidata.org/entity/Q37608369

about

Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer.GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis

P2860

Q49486938-37CC90BE-F0F9-4E24-A868-B037900EE6AA Q57287602-EADB48E2-6C47-494C-BF6A-1A8B2D6F489B Q61798737-571c7d84-4cb0-6fc7-2de0-88b7d983e36c

P2860

CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.

http://www.wikidata.org/entity/Q37608369

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@en

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@nl

type

label

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@en

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@nl

prefLabel

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@en

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@nl

P1433

Q37608369-B7FC7123-AC57-4D2D-9A65-AF242270B6BC

P1476

Q37608369-C168B5A1-8AA0-41FB-AD7E-5FDFD9899199

P2093

Q37608369-0B4F3500-F818-47AE-ABDD-C1974C37368B

Q37608369-430D65C9-13C0-4BE2-9BD2-3B13C66B9501

Q37608369-708D5490-E6AF-4950-8722-ADB79D0045B7

Q37608369-7C406ADB-B4F7-4743-97F9-DDF657AFF35E

Q37608369-A6F4DD57-A8BA-42D1-851D-FBA4B96C343E

Q37608369-B2BBD4F1-1765-4F01-AF1C-A00EC6EDC45F

Q37608369-D974B3D2-F058-4235-A88A-233C1895DB6F

P2860

Q37608369-090D9D8F-124B-4EB8-9F4B-F7D781B73060

Q37608369-0AA5BE49-173F-4357-948C-96D3AAFB2D5A

Q37608369-206C0AF9-1F7C-4189-A0D0-23D6EC238363

Q37608369-2A899E68-9C27-4800-B46A-7A49A995D81D

Q37608369-2CCF8AD5-2E00-4E9D-B4D3-A70FA0CC00FF

Q37608369-4FAED5AF-66D6-4840-8C5C-B2C7EA8E1FDB

Q37608369-578C233F-6DA3-4D7C-AB4F-4F75ECA059ED

Q37608369-5FAC8919-EBE6-4AAD-9894-C702C6C18E2D

Q37608369-6230269D-80BF-424A-A8A1-E94E60654E30

Q37608369-65F8B27D-DAF8-4580-88F8-140AEE07B710

P304

Q37608369-1993FE36-D4D7-49CF-8167-24BA0BFAB940

P31

Q37608369-0550bc87-796a-4ac8-a020-f02c174913dd

Q37608369-7AEFE569-35BE-40B5-B64F-C5BF42209DCE

P356

Q37608369-1B179D2B-9F3E-4F3B-ACE6-47DB7B7636CA

P407

Q37608369-F92B1B81-2F42-4000-B64B-5EC2971141D9

P433

Q37608369-1FA13DA3-1973-4649-84F9-99AE44658AAE

P478

Q37608369-E0E6B6C9-C2DB-43E6-ACD4-4F784076477E

P577

Q37608369-5B1F7E54-A330-492E-88C5-5510BC573CAB

P698

Q37608369-210A7CFD-57B1-426E-AB38-DF44DE02C640

P921

Q37608369-0386DC05-D97B-423C-85A9-66A52AA79C13

P932

Q37608369-29D82256-2B75-4BC9-B7B1-092036892C1C

P356

MD.0000000000005603

P1433

P1476

CD44v6: A metastasis-associate ...... s with heterogeneity analysis.

@en

P2093

Chuan Li

http://www.w3.org/2001/XMLSchema#string

Fei Huang

http://www.w3.org/2001/XMLSchema#string

Li Lu

http://www.w3.org/2001/XMLSchema#string

Tong Liu

http://www.w3.org/2001/XMLSchema#string

Weidong Li

http://www.w3.org/2001/XMLSchema#string

Weihua Fu

http://www.w3.org/2001/XMLSchema#string

Zhicheng Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of three members of the human SR family of pre-mRNA splicing factors

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer

Gastric cancer stem cells: a novel therapeutic target

Stem cells in gastric cancer

Global cancer statistics, 2012

Global cancer statistics, 2002

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Practical methods for incorporating summary time-to-event data into meta-analysis

Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β-catenin pathway

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.

P304

e5603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000005603

http://www.w3.org/2001/XMLSchema#string

P407

P433

50

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27977599

http://www.w3.org/2001/XMLSchema#string

P921

P932

5268045

http://www.w3.org/2001/XMLSchema#string